Skip to main content
Fig. 6 | Journal of Ophthalmic Inflammation and Infection

Fig. 6

From: Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye – evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN®)

Fig. 6

Angiograms from patient with retinal vasculitis before a and in excess of 3 years after treatment with the 0.2 μg/day FAc intravitreal implant b. Left panels: right eye; right panels, left eye; top panels, wide-field colour fundus photos; bottom panels, fundus fluorescein angiography. Images in Fig. 6 A were taken in July 2015. The patient was treated bilaterally with ILUVIEN in January and February 2016 (right and left eyes, respectively) and the images in Fig. 6, obtained in September 2019, were obtained 3 years after treatment with the 0.2 μg/day FAc implant

Back to article page